Blood-brain barrier and retroviral infections

Virulence

Volumn 3, Issue 2, 2012, Pages 222-229

  Miller, Florence ^a,c   Afonso, Philippe V ^b,d   Gessain, Antoine ^b   Ceccaldi, Pierre Emmanuel ^b,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Blood brain barrier; Endothelial cell; HIV; HTLV 1; Retrovirus

Indexed keywords

ANTIRETROVIRUS AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCCLUDIN; PROTEIN ZO1; PROTEIN ZO2; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIVIRAL THERAPY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; ENDOTHELIUM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HIV ENCEPHALITIS; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMORAL IMMUNITY; NONHUMAN; NUTRIENT; PROTEIN EXPRESSION; RETROVIRUS INFECTION; REVIEW; SOLUTE; TIGHT JUNCTION; TRANSCYTOSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84862855314     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.19697     Document Type: Review

References (110)

1. Romero JR, Newland JG. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 2003; 14:72-82; PMID: 12881794; http://dx.doi.org/10.1053/spid.2003.127223
2. Ceccaldi PE, Gillet JP, Tsiang H. Inhibition of the transport of rabies virus in the central nervous system. J Neuropathol Exp Neurol 1989; 48: 620-30; PMID:2477505; http://dx.doi.org/10.1097/ 00005072-198911000-00004
3. Ceccaldi PE, Lucas M, Despres P. New insights on the neuropathology of West Nile virus. FEMS Microbiol Lett 2004; 233:1-6; PMID:15098543; http://dx.doi. org/10.1016/j.femsle.2004.01.035
4. Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 2011; 12:169-82; PMID:21331083; http:// dx.doi.org/10.1038/nrn2995
5. Cipolla MJ. The Cerebral Circulation. San Rafael (CA), 2009.
6. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005; 28:202-8; PMID:15808355; http://dx.doi.org/ 10.1016/j.tins.2005.02.001
7. Pan W, Kastin AJ. Why study transport of peptides and proteins at the neurovascular interface. Brain Res Brain Res Rev 2004; 46:32-43; PMID:15297153; http://dx.doi.org/10.1016/j.brainresrev.2004.04.006
8. Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003; 61:39-78; PMID:14674608
9. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34:207-17; PMID:6033532; http://dx.doi. org/10.1083/jcb.34.1.207
10. Bonkowski D, Katyshev V, Balabanov RD, Borisov A, Dore-Duffy P. The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 2011; 8:8; PMID: 21349156; http://dx.doi.org/10.1186/2045-8118-8-8
11. Nag S. Morphology and properties of astrocytes. Methods Mol Biol 2011; 686:69-100; PMID: 21082367; http://dx.doi.org/10.1007/978-1-60761-938-3_3
12. Weiss N, Miller F, Cazaubon S, Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 2009; 1788: 842-57; PMID:19061857; http://dx.doi.org/10.1016/ j.bbamem.2008.10.022
13. Correale J, Villa A. Cellular elements of the bloodbrain barrier. Neurochem Res 2009; 34:2067-77; PMID:19856206; http://dx.doi.org/10.1007/s11064-009-0081-y
14. Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 1969; 40:648-77; PMID:5765759; http://dx.doi.org/10.1083/jcb.40.3.648
15. Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001; 46:247-79; PMID: 11259843; http://dx.doi.org/10.1016/S0169-409X (00)00139-3
16. Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6:591-602; PMID:16025095; http://dx.doi.org/10.1038/nrn1728
17. Engelhardt B, Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 2004; 34:2955-63; PMID:15376193; http://dx.doi.org/10. 1002/eji.200425327
18. Nassif X, Bourdoulous S, Eugène E, Couraud PO. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 2002; 10:227-32; PMID: 11973156; http://dx.doi.org/10.1016/S0966-842X (02)02349-1
19. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992; 42:1472-6; PMID:1641138
20. Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8:410-24; PMID:11939699; http://dx.doi.org/10.1017/ S1355617702813212
21. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19:525-35; PMID:3014994; http://dx.doi.org/ 10.1002/ana.410190603
22. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19: 517-24; PMID:3729308; http://dx.doi.org/10.1002/ ana.410190602
23. Wiley CA, Schrier RD, Morey M, Achim C, Venable JC, Nelson JA. Pathogenesis of HIV encephalitis. Acta Pathol Jpn 1991; 41:192-6; PMID:2068943
24. Toborek M, Lee YW, Flora G, Pu H, András IE, Wylegala E, et al. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 2005; 25:181-99; PMID:15962513; http://dx.doi.org/10.1007/s10571-004-1383-x
25. Budka H. The definition of HIV-specific neuropathology. Acta Pathol Jpn 1991; 41:182-91; PMID: 2068942
26. Tardieu M. HIV-1-related central nervous system diseases. Curr Opin Neurol 1999; 12:377-81; PMID: 10555824; http://dx.doi.org/10.1097/00019052-199908000-00002
27. Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994; 7:265-71; PMID:7906304
28. Avison MJ, Nath A, Berger JR. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci 2002; 25: 468-73; PMID:12183208; http://dx.doi.org/10.1016/ S0166-2236(02)02234-8
29. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999; 155:1915-27; PMID:10595922; http://dx.doi.org/10.1016/ S0002-9440(10)65511-3
30. Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neurobiol 2000; 26:356-60; PMID:10931369; http://dx.doi.org/ 10.1046/j.1365-2990.2000.00255.x
31. Mogensen TH, Paludan SR. Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth. Eur Cytokine Netw 2001; 12:382-90; PMID:11566618
32. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 2001; 65:131-50; PMID:11238989; http:// dx.doi.org/10.1128/MMBR.65.1.131-150.2001
33. Gabuzda DH, Sobel RA. HIV antigen in brains of patients with AIDS. Ann Neurol 1987; 22:668; PMID: 3480698; http://dx.doi.org/10.1002/ana.410220526
34. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12:1327-32; PMID:9708412; http://dx.doi.org/10. 1097/00002030-199811000-00014
35. Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, et al. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis 1996; 174:1098-101; PMID:8896515; http://dx.doi.org/10.1093/infdis/174.5.1098
36. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 1999; 46:391-8; PMID:10482270; http://dx.doi.org/10. 1002/1531-8249(199909)46:3,391::AID-ANA15. 3.0.CO;2-0
37. Marshall DC, Wyss-Coray T, Abraham CR. Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci Lett 1998; 254:97-100; PMID: 9779929; http://dx.doi.org/10.1016/S0304-3940(98) 00674-0
38. Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, et al. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 1998; 178:854-7; PMID:9728558; http://dx.doi.org/ 10.1086/515342
39. Weeks BS, Lieberman DM, Johnson B, Roque E, Green M, Loewenstein P, et al. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J Neurosci Res 1995; 42:34-40; PMID: 8531224; http://dx.doi.org/10.1002/jnr.490420105
40. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 2000; 6:145-55; PMID:10822328; http://dx.doi.org/10.3109/13550280009013158
41. Arese M, Ferrandi C, Primo L, Camussi G, Bussolino F. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J Immunol 2001; 166:1380-8; PMID:11145723
42. Oshima T, Flores SC, Vaitaitis G, Coe LL, Joh T, Park JH, et al. HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogenactivated protein kinase-dependent pathways. AIDS 2000; 14:475-82; PMID:10780709; http://dx.doi.org/ 10.1097/00002030-200003310-00002
43. Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B, et al. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 2003; 24:224-37; PMID: 14550782; http://dx.doi.org/10.1016/S1044-7431 (03)00171-4
44. András IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003; 74:255-65; PMID:14515355; http://dx.doi.org/10.1002/jnr.10762
45. Toborek M, Lee YW, Pu H, Malecki A, Flora G, Garrido R, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem 2003; 84:169-79; PMID:12485413; http://dx.doi.org/10.1046/j.1471-4159.2003.01543.x
46. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996; 98:1979-90; PMID:8903316; http://dx.doi.org/ 10.1172/JCI119002
47. Acheampong EA, Parveen Z, Muthoga LW, Kalayeh M, Mukhtar M, Pomerantz RJ. Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol 2005; 79:4257-69; PMID:15767427; http://dx.doi.org/10.1128/JVI. 79.7.4257-4269.2005
48. Price TO, Ercal N, Nakaoke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 2005; 1045:57-63; PMID:15910762; http://dx.doi.org/10.1016/j.brainres. 2005.03.031
49. Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 2005; 64:498-505; PMID: 15977641
50. Nakamuta S, Endo H, Higashi Y, Kousaka A, Yamada H, Yano M, et al. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and-2 in human brain microvascular endothelial cells. J Neurovirol 2008; 14:186-95; PMID:18569453; http://dx.doi.org/ 10.1080/13550280801993630
51. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 2007; 27:123-34; PMID:16685256; http://dx.doi.org/ 10.1038/sj.jcbfm.9600330
52. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997; 151:1341-51; PMID: 9358760
53. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS 1998; 12:1021-6; PMID:9662198; http://dx.doi.org/10.1097/00002030-199809000-00009
54. Moses AV, Bloom FE, Pauza CD, Nelson JA. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A 1993; 90:10474-8; PMID:7504264; http:// dx.doi.org/10.1073/pnas.90.22.10474
55. Moses AV, Nelson JA. HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv Neuroimmunol 1994; 4:239-47; PMID:7533040; http://dx.doi.org/10.1016/ S0960-5428(06)80262-7
56. Sporer B, Koedel U, Paul R, Kohleisen B, Erfle V, Fontana A, et al. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 2000; 102:125-30; PMID:10636480; http://dx.doi.org/ 10.1016/S0165-5728(99)00170-8
57. Rostad SW, Sumi SM, Shaw CM, Olson K, McDougall JK. Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses 1987; 3:363-73; PMID:3447627; http://dx.doi.org/10. 1089/aid.1987.3.363
58. Ward JM, O'Leary TJ, Baskin GB, Benveniste R, Harris CA, Nara PL, et al. Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987; 127:199-205; PMID:3472469
59. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986; 83:7089-93; PMID: 3018755; http://dx.doi.org/10.1073/pnas.83.18.7089
60. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39:705-11; PMID:8651642; http://dx.doi.org/ 10.1002/ana.410390606
61. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 2000; 6(Suppl 1):S70-81; PMID:10871768
62. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005; 26:485-95; PMID:16039904; http://dx.doi.org/10. 1016/j.it.2005.07.004
63. Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010; 7:30; PMID:20374632; http:// dx.doi.org/10.1186/1742-4690-7-30
64. Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 2000; 6(Suppl 1):S82-5; PMID:10871769
65. Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000; 14:2709-13; PMID:11125889; http://dx. doi.org/10.1097/00002030-200012010-00010
66. Fantuzzi L, Spadaro F, Vallanti G, Canini I, Ramoni C, Vicenzi E, et al. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood 2003; 102:2334-7; PMID: 12805068; http://dx.doi.org/10.1182/blood-2002-10-3275
67. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002; 99:13795-800; PMID:12374865; http://dx.doi.org/ 10.1073/pnas.202357499
68. Yadav A, Collman RG. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 2009; 4:430-47; PMID:19768553; http://dx.doi.org/10.1007/s11481-009-9174-2
69. Banks WA, Kastin AJ, Brennan JM, Vallance KL. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol 1999; 156:165-71; PMID:10192787; http://dx.doi. org/10.1006/exnr.1998.7011
70. Stolp HB, Dziegielewska KM, Ek CJ, Potter AM, Saunders NR. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 2005; 22:2805-16; PMID: 16324115; http://dx.doi.org/10.1111/j.1460-9568. 2005.04483.x
71. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158:3499-510; PMID:9120312
72. Wang H, Sun J, Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the bloodbrain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J Virol 2008; 82:7591-600; PMID: 18508884; http://dx.doi.org/10.1128/JVI.00768-08
73. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol 1988; 25: 456-67; PMID:2850650; http://dx.doi.org/10.1177/ 030098588802500609
74. Sharer LR, Baskin GB, Cho ES, Murphey-Corb M, Blumberg BM, Epstein LG. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol 1988; 23(Suppl):S108-12; PMID: 2831797; http://dx.doi.org/10.1002/ana.410230727
75. Chakrabarti L, Hurtrel M, Maire MA, Vazeux R, Dormont D, Montagnier L, et al. Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol 1991; 139:1273-80; PMID:1750503
76. Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L. Early SIV encephalopathy. J Med Primatol 1991; 20:159-66; PMID: 1942006
77. Luabeya MK, Dallasta LM, Achim CL, Pauza CD, Hamilton RL. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathol Appl Neurobiol 2000; 26:454-62; PMID:11054186; http://dx.doi.org/10.1046/j.1365-2990.2000.00275.x
78. Ryan G, Grimes T, Brankin B, Mabruk MJ, Hosie MJ, Jarrett O, et al. Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J Neurovirol 2005; 11:337-45; PMID:16162477; http://dx.doi.org/10.1080/13550280500186445
79. Steffan AM, Lafon ME, Gendrault JL, Koehren F, De Monte M, Royer C, et al. Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels. J Gen Virol 1994; 75: 3647-53; PMID:7996160; http://dx.doi.org/10.1099/ 0022-1317-75-12-3647
80. Fletcher NF, Meeker RB, Hudson LC, Callanan JJ. The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome. Vet J 2011; 188:260-9; PMID:20418131; http://dx.doi.org/10. 1016/j.tvjl.2010.03.022
81. Georgsson G. Neuropathologic aspects of lentiviral infections. Ann N Y Acad Sci 1994; 724:50-67; PMID:8030977; http://dx.doi.org/10.1111/j.1749-6632.1994.tb38895.x
82. Zink MC, Yager JA, Myers JD. Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats. Am J Pathol 1990; 136:843-54; PMID:2327471
83. Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, et al. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986; 2:104-5; PMID:2873363; http://dx.doi.org/10.1016/ S0140-6736(86)91636-3
84. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2; PMID: 2871307; http://dx.doi.org/10.1016/S0140-6736(86) 91298-5
85. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10; PMID:2863442; http://dx.doi.org/10.1016/S0140-6736(85)92734-5
86. Jernigan M, Morcos Y, Lee SM, Dohan FC, Jr., Raine C, Levin MC. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology 2003; 60:1320-7; PMID:12707436
87. Ozden S, Seilhean D, Gessain A, Hauw JJ, Gout O. Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient. Clin Infect Dis 2002; 34:855-60; PMID:11830796; http:// dx.doi.org/10.1086/338868
88. Cartier L, Ramirez E. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Arch Virol 2005; 150:743-53; PMID:15592888; http://dx. doi.org/10.1007/s00705-004-0443-3
89. Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 2000; 182:1044-50; PMID:10979898; http://dx.doi.org/10. 1086/315844
90. Kuroda Y, Matsui M, Takashima H, Kurohara K. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 45:133-6; PMID:8331158; http://dx.doi.org/10.1016/0165-5728(93)90173-V
91. Kuroda Y, Matsui M. Cerebrospinal fluid interferongamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:223-6; PMID:8429106; http://dx.doi.org/10.1016/0165-5728(93)90014-P
92. Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:127-30; PMID:8429097; http://dx.doi.org/10.1016/0165-5728(93)90001-F
93. Brosnan CF, Selmaj K, Raine CS. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988; 18:87-94; PMID:3257971; http://dx.doi.org/10.1016/0165-5728(88)90137-3
94. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37:167-75; PMID:7847858; http://dx.doi.org/10.1002/ana.410370206
95. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186(Suppl 2):S187-92; PMID: 12424696; http://dx.doi.org/10.1086/344269
96. Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant JC, et al. IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol 1995; 77:282-90; PMID:7586738; http://dx. doi.org/10.1006/clin.1995.1154
97. Romero IA, Prevost MC, Perret E, Adamson P, Greenwood J, Couraud PO, et al. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 2000; 74:6021-30; PMID:10846084; http://dx.doi.org/10. 1128/JVI.74.13.6021-6030.2000
98. Afonso PV, Ozden S, Prevost MC, Schmitt C, Seilhean D, Weksler B, et al. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tightjunction disorganization. J Immunol 2007; 179:2576-83; PMID:17675520
99. Khuth ST, Strazielle N, Giraudon P, Belin MF, Ghersi-Egea JF. Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem 2005; 94: 1580-93; PMID:16026393; http://dx.doi.org/10. 1111/j.1471-4159.2005.03309.x
100. Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P, et al. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog 2008; 4:e1000205; PMID:19008946; http://dx.doi. org/10.1371/journal.ppat.1000205
101. Lezin A, Gillet N, Olindo S, Signaté A, Grandvaux N, Verlaeten O, et al. Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood 2007; 110:3722-8; PMID:17717136; http://dx.doi.org/10.1182/blood-2007-04-085076
102. Boissé L, Gill MJ, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 2008; 26:799-819, x; PMID:18657727; http://dx.doi.org/10.1016/j.ncl. 2008.04.002
103. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20:15-24; PMID:18240059; http://dx.doi.org/10.1080/ 09540260701862037
104. Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, et al. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J Clin Immunol 2008; 28:528-41; PMID:18574677; http://dx.doi. org/10.1007/s10875-008-9208-1
105. Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol 1998; 4:619-26; PMID:10065903; http://dx.doi.org/10.3109/ 13550289809114228
106. Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, et al. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv Exp Med Biol 1998; 437:199-205; PMID:9666272; http://dx.doi.org/10.1007/978-1-4615-5347-2_22
107. Gandhi N, Saiyed ZM, Napuri J, Samikkannu T, Reddy PV, Agudelo M, et al. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J Neurovirol 2010; 16:294-305; PMID: 20624003; http://dx.doi.org/10.3109/13550284.2010. 499891
108. Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, et al. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol 2008; 181:6406-16; PMID: 18941231
109. Manda VK, Mittapalli RK, Bohn KA, Adkins CE, Lockman PR. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem 2010; 115:1495-507; PMID:20950334; http://dx.doi. org/10.1111/j.1471-4159.2010.07054.x
110. Manda VK, Mittapalli RK, Geldenhuys WJ, Lockman PR. Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity. J Neurochem 2010; 115:515-25; PMID:20722969; http://dx.doi.org/10. 1111/j.1471-4159.2010.06948.x